Seventure holds second close for biotech fund on €100m

The vehicle, which has a €120m target, was launched in February 2013 and reached a first close in December 2013 on €62m.

The VC stated it has additional investors in the pipeline and expects the fund to reach its target.

Investors
Seventure stated the latest fundraising saw commitments from financial investors, strategic investors and entrepreneurs. The vehicle had previously attracted commitments from corporates, family offices and institutional investors, with LPs including Danone, Tereos and Tornier.

Investments
The life sciences fund has a specific focus on health nutrition, resulting in its backing by dairy business Danone. Health for Life Capital explores opportunities linked to research involving the microbiome, which is the aggregate of microorganisms present in the human body.

The vehicle invests predominantly in Europe, but also targets North America and Asia. Most recently, it made a €1m investment in Lyon-based MaaT Pharma. Other European investments include Enterome Bioscience, Laboratoires Nutrition & Cardiométabolisme, and Humedics.

People
Isabelle de Cremoux is president and CEO at Seventure.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• France
• Healthcare
• France
• Seventure (SPEF)